Inventor · disambiguated record
Jonathan Marc Cohen
Also filed as: COHEN JONATHAN M · COHEN JONATHAN MARC
14 granted patents·6 pending applications·676 citations·filing 1984–2019
94Inventor score
Top patents by PatentIndex Score
20 records- 0196US7915229B2Compositions containing piperacillin and tazobactam useful for injectionWYETH CORP·Filed 2009·Granted Mar 29, 2011·35 cites·18 claims
- 0295US6900184B2Compositions containing pipercillin and tazobactam useful for injectionWYETH CORP·Filed 2003·Granted May 31, 2005·66 cites·90 claims
- 0394US4708834APreparation of gelatin-encapsulated controlled release compositionPHARMACAPS INC·Filed 1986·Granted Nov 24, 1987·206 cites·5 claims
- 0491US4795642AGelatin-encapsulated controlled-release compositionPHARMACAPS INC·Filed 1987·Granted Jan 3, 1989·138 cites·19 claims
- 0589US9314461B2Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2013·Granted Apr 19, 2016·9 cites·40 claims
- 0689US8524276B2Oral formulations and lipophilic salts of methylnaltrexoneSHAH SYED M·Filed 2011·Granted Sep 3, 2013·11 cites·27 claims
- 0789US7498312B2Compositions containing piperacillin and tazobactam useful for injectionWYETH CORP·Filed 2004·Granted Mar 3, 2009·28 cites·37 claims
- 0889US5427778AGel formulations containing growth factors and acrylamide polymerETHICON INC·Filed 1992·Granted Jun 27, 1995·93 cites·2 claims
- 0987US8956651B2Oral formulations and lipophilic salts of methylnal trexoneWYETH LLC·Filed 2013·Granted Feb 17, 2015·6 cites·31 claims
- 1087US4591496AProcess for making systems for the controlled release of macromoleculesMASSACHUSETTS INST TECHNOLOGY·Filed 1984·Granted May 27, 1986·70 cites·7 claims
- 1185US8133883B2Compositions containing piperacillin and tazobactam useful for injectionCOHEN JONATHAN M·Filed 2011·Granted Mar 13, 2012·10 cites·15 claims
- 1284US10307417B2Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2018·Granted Jun 4, 2019·2 cites·29 claims
- 1380US10507206B2Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2019·Granted Dec 17, 2019·1 cites·25 claims
- 1479US10376505B2Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2018·Granted Aug 13, 2019·1 cites·30 claims
- 1577US2020121673A1Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2019·Application pending·0 cites
- 1662US2008051691A1Implantable shunt or catheter enabling gradual delivery of therapeutic agentsWYETH CORP·Filed 2007·Application pending·0 cites
- 1759US2016206612A1Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2016·Application pending·0 cites
- 1858US2016089521A1Implantable shunt or catheter enabling gradual delivery of therapeutic agentsWYETH LLC·Filed 2015·Application pending·0 cites
- 1952US2011060265A1Implantable shunt or catheter enabling gradual delivery of therapeutic agentsWYETH LLC·Filed 2010·Application pending·0 cites
- 2044US2006084639A1Compositions containing piperacillin and tazobactam useful for injectionWYETH CORP·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan Marc Cohen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →